Katsev, A. M. published the artcileStudy of interactions between cationic surface-active antiseptics and serum albumin by bacterial bioluminescence, Application of N1,N10-Bis(2-((2-isopropyl-5-methylcyclohexyl)oxy)-2-oxoethyl)-N1,N1,N10,N10-tetramethyldecane-1,10-diaminium chloride, the publication is Klinicheskaya Laboratornaya Diagnostika (2002), 39-41, database is CAplus and MEDLINE.
Human serum albumin binding of cationic surface-active antiseptics was studied using a Photobacterium phosphoreum K3 strain isolated in the Black Sea. Binding of cationic surface-active proteins to serum albumin led to disappearance of toxic and antibacterial characteristics of miramistin, ethonium, and decametoxin, but not chlorhexidine. The activity of chlorohexidine was reduced by 45-8% in the presence of albumin. Albumin binding capacity towards miramistin was 7.0-8.7%, towards ethonium 8.2-10%, and towards decametoxin 2.4-3%.
Klinicheskaya Laboratornaya Diagnostika published new progress about 38146-42-8. 38146-42-8 belongs to chlorides-buliding-blocks, auxiliary class Achiral Phase-Transfer Catalysts, name is N1,N10-Bis(2-((2-isopropyl-5-methylcyclohexyl)oxy)-2-oxoethyl)-N1,N1,N10,N10-tetramethyldecane-1,10-diaminium chloride, and the molecular formula is C38H74Cl2N2O4, Application of N1,N10-Bis(2-((2-isopropyl-5-methylcyclohexyl)oxy)-2-oxoethyl)-N1,N1,N10,N10-tetramethyldecane-1,10-diaminium chloride.
Referemce:
https://en.wikipedia.org/wiki/Chloride,
Chlorides – an overview | ScienceDirect Topics